Jiang K - Search Results

1

The Multifaceted Roles of RCC1 in Tumorigenesis.

Ren X, Jiang K, Zhang F. Ren X, et al. Among authors: jiang k. Front Mol Biosci. 2020 Sep 15;7:225. doi: 10.3389/fmolb.2020.00225. eCollection 2020. Front Mol Biosci. 2020. PMID: 33102517 Free PMC article. Review.

2

BCLAF1, a functional partner of BACH1, participates in DNA damage response.

Jiang K, Ding Y, Dong C, Shan F, Guo K, Zhang J, Zhang F. Jiang K, et al. DNA Repair (Amst). 2022 Oct;118:103371. doi: 10.1016/j.dnarep.2022.103371. Epub 2022 Jul 21. DNA Repair (Amst). 2022. PMID: 35930920

3

Plasma-induced oxygen defects in titanium dioxide to address the long-term stability of pseudocapacitive MnO₂ anode for lithium ion batteries.

Zhang Z, Ran K, Wang W, Cao S, Zhao R, Zhou H, Xue W, Li H, Wang W, Min Z, Jiang K, Wang K. Zhang Z, et al. Among authors: jiang k. J Colloid Interface Sci. 2024 Feb 15;656:116-124. doi: 10.1016/j.jcis.2023.11.087. Epub 2023 Nov 15. J Colloid Interface Sci. 2024. PMID: 37984167

4

NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway.

Sun C, Sun L, Jiang K, Gao DM, Kang XN, Wang C, Zhang S, Huang S, Qin X, Li Y, Liu YK. Sun C, et al. Among authors: jiang k. Int J Biochem Cell Biol. 2013 Jun;45(6):1099-108. doi: 10.1016/j.biocel.2013.02.017. Epub 2013 Mar 7. Int J Biochem Cell Biol. 2013. PMID: 23474366

5

Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases.

Jiang K, Shang S, Li W, Guo K, Qin X, Zhang S, Liu Y. Jiang K, et al. Glycoconj J. 2015 Dec;32(9):657-64. doi: 10.1007/s10719-015-9614-6. Epub 2015 Sep 5. Glycoconj J. 2015. PMID: 26342810

6

GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness.

Jiang K, Li W, Zhang Q, Yan G, Guo K, Zhang S, Liu Y. Jiang K, et al. Oncotarget. 2016 Apr 26;7(17):23530-41. doi: 10.18632/oncotarget.8120. Oncotarget. 2016. PMID: 26993603 Free PMC article.

7

Aberrant expression of Golgi protein 73 is indicative of a poor outcome in hepatocellular carcinoma.

Jiang K, Li W, Shang S, Sun L, Guo K, Zhang S, Liu Y. Jiang K, et al. Oncol Rep. 2016 Apr;35(4):2141-50. doi: 10.3892/or.2016.4601. Epub 2016 Jan 28. Oncol Rep. 2016. PMID: 26820712

8

Histidine-rich glycoprotein function in hepatocellular carcinoma depends on its N-glycosylation status, and it regulates cell proliferation by inhibiting Erk1/2 phosphorylation.

Zhang Q, Jiang K, Li Y, Gao D, Sun L, Zhang S, Liu T, Guo K, Liu Y. Zhang Q, et al. Among authors: jiang k. Oncotarget. 2015 Oct 6;6(30):30222-31. doi: 10.18632/oncotarget.4997. Oncotarget. 2015. PMID: 26336134 Free PMC article.

9

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.

Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y. Wang C, et al. Among authors: jiang k. BMC Cancer. 2012 May 4;12:166. doi: 10.1186/1471-2407-12-166. BMC Cancer. 2012. PMID: 22559167 Free PMC article.

10

Corrigendum to "NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway" [Int. J. Biochem. Cell Biol. (2013) 1099-1108].

Sun C, Sun L, Jiang K, Gao DM, Kang XN, Wang C, Zhang S, Huang S, Qin X, Li Y, Liu YK. Sun C, et al. Among authors: jiang k. Int J Biochem Cell Biol. 2018 Dec;105:144. doi: 10.1016/j.biocel.2018.09.020. Epub 2018 Oct 9. Int J Biochem Cell Biol. 2018. PMID: 30314944 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,756 results

Search Page

Filters